Skip to main content

Table 2 Adverse reactions within 7 days after the first and second dose of vaccination

From: Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals

Adverse reaction

PLWH group

(n = 46)

Control group

(n = 38)

P value

First dose

 Total adverse reactions

14 (30.4)

12 (31.6)

0.91

 Systemic reactions

5 (10.9)

2 (5.3)

0.35

 Coughing

1 (2.2)

2 (5.3)

0.45

 Diarrhea

0

0

–

 Fatigue

4 (8.7)

0

0.06

 Fever

0

0

 

 Headache

0

0

–

 Nausea and vomiting

0

0

–

 Pruritus (non-inoculated site)

0

0

–

 Local reactions

14 (30.4)

11 (28.9)

0.88

 Itching

0

0

-

 Pain

11 (23.9)

9 (23.7)

0.98

 Redness

1 (2.2)

1 (2.6)

0.89

 Swelling

2 (4.3)

1 (2.6)

0.67

 Rash

0

0

–

Second dose

 Total adverse reactions

5 (10.9)

9 (23.7)

0.12

 Systemic reactions

1 (2.2)

3 (7.9)

0.22

 Coughing

0

2 (5.3)

0.12

 Diarrhea

0

0

–

 Fatigue

1 (2.2)

1 (2.6)

0.89

 Fever

0

0

 

 Headache

0

0

–

 Nausea and vomiting

0

0

–

 Pruritus (non-inoculated site)

0

0

–

 Local reactions

4 (8.7)

6 (13.8)

0.32

 Itching

0

0

-

 Pain

4 (8.7)

5 (13.2)

0.51

 Redness

0

1 (2.6)

0.27

 Swelling

0

0

–

 Rash

0

0

–

  1. Data are shown as No. of participants with the event (%). A participant was only counted once in the specific reaction category even though a participant could have more than 1 adverse reaction. P value calculated using Chi-square test or Fisher’s exact test